In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a)

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 322-327

  Frischmann, Michael E ^a   Ikewaki, Katsunori ^b   Trenkwalder, Evi ^a   Lamina, Claudia ^a   Dieplinger, Benjamin ^c   Soufi, Muhidien ^d   Schweer, Horst ^d   Schaefer, Juergen R ^d   König, Paul ^a   Kronenberg, Florian ^a   Dieplinger, Hans ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

HMW apo(a) isoforms; In vivo kinetics; LMW apo(a) isoforms; Lp(a) assembly; Stable isotopes

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B100; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOTOPE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; DEUTERIUM; LEUCINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPUTER PROGRAM; CONTROLLED STUDY; FRACTIONAL SYNTHESIS RATE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN SYNTHESIS; TRIACYLGLYCEROL BLOOD LEVEL; BIOLOGICAL MODEL; BLOOD; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MIDDLE AGED; PROTEIN MULTIMERIZATION;

ADULT; APOLIPOPROTEIN B-100; APOLIPOPROTEINS A; DEUTERIUM; HUMANS; INFUSIONS, INTRAVENOUS; KINETICS; LEUCINE; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROTEIN MULTIMERIZATION; YOUNG ADULT;

EID: 84869491748     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.031     Document Type: Article

References (45)

1. Utermann G. Lipoprotein(a). The metabolic bases of inherited disease 2001, 2753-2787. McGraw Hill Inc., New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Clarke R., Peden J.F., Hopewell J.C., et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009, 361:2518-2528.
3. Kraft H.G., Köchl S., Menzel H.J., Sandholzer C., Utermann G. The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992, 90:220-230.
4. Bostom A.G., Gagnon D.R., Cupples L.A., et al. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women: the Framingham Heart Study. Circulation 1994, 90:1688-1695.
5. Erqou S., Kaptoge S., Perry P.L., et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. J Am Med Assoc 2009, 302:412-423.
6. Krempler F., Kostner G.M., Bolzano K., Sandhofer F. Turnover of lipoprotein(a) in man. J Clin Invest 1980, 65:1483-1490.
7. Rader D.J., Cain W., Ikewaki K., et al. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest 1994, 93:2758-2763.
8. Dube J.B., Boffa M.B., Hegele R.A., Koschinsky M.L. Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol 2012, 23:133-140.
9. Dieplinger H., Utermann G. The seventh myth of lipoprotein(a): where and how is it assembled?. Curr Opin Lipidol 1999, 10:275-283.
10. Brunner C., Kraft H.G., Utermann G., Müller H.J. Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc Natl Acad Sci U S A 1993, 90:11643-11647.
11. Trieu V.N., McConathy W.J. A two-step model for lipoprotein(a) formation. J Biol Chem 1995, 270:15471-15474.
12. McCormick S.P., Ng J.K., Taylor S., Flynn L.M., Hammer R.E., Young S.G. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a). Proc Natl Acad Sci U S A 1995, 92:10147-10151.
13. Becker L., Nesheim M.E., Koschinsky M.L. Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation. Biochemistry 2006, 45:9919-9928.
14. Gething M.J., Sambrook J. Protein folding in the cell. Nature 1992, 355:33-45.
15. Hurtley S.M., Helenius A. Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol 1989, 5:277-307.
16. White A.L., Lanford R.E. Biosynthesis and metabolism of lipoprotein(a). Curr Opin Lipidol 1995, 6:75-80.
17. Lobentanz E.M., Krasznai K., Gruber A., et al. Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells. Biochemistry 1998, 37:5417-5425.
18. Koschinsky M.L., Côté G.P., Gabel B., Van der Hoek Y.Y. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem 1993, 268:19819-19825.
19. Bonen D.K., Hausman A.M.L., Hadjiagapiou C., Skarosi S.F., Davidson N.O. Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a). J Biol Chem 1997, 272:5659-5667.
20. Krempler F., Kostner G.M., Bolzano K., Sandhofer F. Lipoprotein(a) is not a metabolic product of other lipoproteins containing apolipoprotein B. Biochim Biophys Acta 1979, 575:63-70.
21. Krempler F., Kostner G., Bolzano K., Sandhofer F. Studies on the metabolism of the lipoprotein Lp(a) in man. Atherosclerosis 1978, 30:57-65.
22. Morrisett J., Gaubatz J., Nava L., et al. Metabolism of apo(a) and apoB-100 in human lipoprotein(a). Drugs affecting lipid metabolism 1993, 161-167. Kluwer Academic Publishers and Fondazione Giovanni Lorenzini, Dordrecht, The Netherlands. A. Catapano, A.M. Gotto, L.C. Smith, R. Paoletti (Eds.).
23. Su W., Campos H., Judge H., Walsh B.W., Sacks F.M. Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab 1998, 83:3267-3276.
24. Demant T., Seeberg K., Bedynek A., Seidel D. The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans. Atherosclerosis 2001, 157:325-339.
25. Jenner J.L., Seman L.J., Millar J.S., et al. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings. Metabolism 2005, 54:361-369.
26. Kronenberg F., Lobentanz E.-M., König P., Utermann G., Dieplinger H. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994, 35:1318-1328.
27. Kostner G.M., Ibovnik A., Holzer H., Grillhofer H. Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard. J Lipid Res 1999, 40:2255-2263.
28. McLean J.W., Tomlinson J.E., Kuang W.-J., et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987, 300:132-137.
29. Marcovina S.M., Albers J.J., Gabel B., Koschinsky M.L., Gaur V.P. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 1995, 41:246-255.
30. Kronenberg F., Neyer U., Lhotta K., et al. The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up. J Am Soc Nephrol 1999, 10:1027-1036.
31. Dieplinger H., Lackner C., Kronenberg F., et al. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993, 91:397-401.
32. Menzel H.J., Utermann G. Apolipoprotein E phenotyping from serum by western blotting. Electrophoresis 1986, 11:492-495.
33. Schaefer J.R., Rader D.J., Ikewaki K., et al. In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemia. Arterioscler Thromb 1992, 12:843-848.
34. Frischmann M.E., Kronenberg F., Trenkwalder E., et al. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int 2007, 71:1036-1043.
35. Barrett P.H., Bell B.M., Cobelli C., et al. SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism 1998, 47:484-492.
36. Cryer D.R., Matsushima T., Marsh J.B., Yudkoff M., Coates P.M., Cortner J.A. Direct measurement of apolipoprotein synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry. J Lipid Res 1986, 27:508-516.
37. Shames D.M., Havel R.J. De novo production of low density lipoproteins: fact or fancy. J Lipid Res 1991, 32:1099-1112.
38. Pietzsch J., Wiedemann B., Julius U., et al. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. J Lipid Res 1996, 37:2074-2087.
39. Packard C.J., Demant T., Stewart J.P., et al. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 2000, 41:305-318.
40. Bouma M.E., Pessah M., Renaud G., Amit N., Catala D., Infante R. Synthesis and secretion of lipoproteins by human hepatocytes in culture. In Vitro Cell Dev Biol 1988, 24:85-90.
41. Kagawa A., Azuma H., Akaike M., Kanagawa Y., Matsumoto T. Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription. J Biol Chem 1999, 274:34111-34115.
42. White A.L., Rainwater D.L., Lanford R.E. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. J Lipid Res 1993, 34:509-517.
43. Dashti N., Alaupovic P., Knight-Gibson C., Koren E. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2. Biochemistry 1987, 26:4837-4846.
44. Kronenberg F., Kronenberg M.F., Kiechl S., et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999, 100:1154-1160.
45. Erqou S., Thompson A., Di Angelantonio E., et al. Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J Am Coll Cardiol 2010, 55:2160-2167.